BRPI0418098A - formulações veterinárias não contendo produtos animais - Google Patents
formulações veterinárias não contendo produtos animaisInfo
- Publication number
- BRPI0418098A BRPI0418098A BRPI0418098-4A BRPI0418098A BRPI0418098A BR PI0418098 A BRPI0418098 A BR PI0418098A BR PI0418098 A BRPI0418098 A BR PI0418098A BR PI0418098 A BRPI0418098 A BR PI0418098A
- Authority
- BR
- Brazil
- Prior art keywords
- animal products
- animal
- veterinary formulations
- binder
- containing animal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
"FORMULAçõES VETERINáRIAS NãO CONTENDO PRODUTOS ANIMAIS". Esta invenção fornece uma formulação veterinária mastigável, que não contém produtos animais, que compreende: - uma quantidade eficaz de um agente farmaceuticamente ativo que compreende: a) pelo menos um ácido de nodulisporamida ou derivado do ácido nodulispórico; ou b) uma combinação compreendendo i) pelo menos um derivado de avermectina ou milbemicina; e ii) pelo menos um composto selecionado do grupo que consiste em praziquantel e pirantel; - pelo menos um aglutinante; - pelo menos um desintegrador; - pelo menos um aroma não contendo produtos animais ou um aroma derivado de uma fonte não animal; - pelo menos um aglutinante; - pelo menos um umectante; - pelo menos um solvente granulante; e - opcionalmente, pelo menos um antioxidante, pelo menos um agente tamponante, pelo menos um conservante, ou pelo menos um corante.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/745,784 US20040151759A1 (en) | 2002-08-16 | 2003-12-23 | Non-animal product containing veterinary formulations |
PCT/US2004/042380 WO2005062782A2 (en) | 2003-12-23 | 2004-12-17 | Non-animal product containing veterinary formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0418098A true BRPI0418098A (pt) | 2007-04-17 |
Family
ID=34739059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0418098-4A BRPI0418098A (pt) | 2003-12-23 | 2004-12-17 | formulações veterinárias não contendo produtos animais |
Country Status (9)
Country | Link |
---|---|
US (1) | US20040151759A1 (pt) |
EP (1) | EP1702056A4 (pt) |
JP (1) | JP2007516285A (pt) |
KR (1) | KR20060126728A (pt) |
CN (1) | CN1972672A (pt) |
AU (1) | AU2004308284A1 (pt) |
BR (1) | BRPI0418098A (pt) |
CR (1) | CR8480A (pt) |
WO (1) | WO2005062782A2 (pt) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060205681A1 (en) * | 2002-06-21 | 2006-09-14 | Maryam Moaddeb | Homogenous paste formulations |
US7976884B2 (en) * | 2003-08-01 | 2011-07-12 | Nestec Ltd. | Edible animal chew toy |
NZ529177A (en) * | 2003-10-24 | 2005-12-23 | Agres Ltd | Administration process for a delivery device that releases the active agent over several days |
WO2006036624A2 (en) * | 2004-09-24 | 2006-04-06 | The Hartz Mountain Corporation | Lipid stabilized formulations |
JP4297042B2 (ja) * | 2004-11-30 | 2009-07-15 | ブラザー工業株式会社 | シート材収納カセット及びそれを備える画像形成装置 |
US7955632B2 (en) * | 2005-12-07 | 2011-06-07 | Bayer B.V. | Process for manufacturing chewable dosage forms for drug delivery and products thereof |
US20080027011A1 (en) * | 2005-12-20 | 2008-01-31 | Hassan Nached | Homogeneous paste and gel formulations |
AU2006100657C4 (en) * | 2006-05-15 | 2009-09-10 | Wyeth | Stabilised formulation |
CA2656019C (en) * | 2006-06-28 | 2016-09-13 | Emisphere Technologies, Inc. | Gallium nitrate formulations |
WO2008077130A2 (en) * | 2006-12-19 | 2008-06-26 | Merial Limited | Homogeneous paste and gel formulations |
NZ552290A (en) * | 2006-12-21 | 2009-05-31 | Bomac Research Ltd | Tablet fomulation |
WO2009062939A1 (en) | 2007-11-15 | 2009-05-22 | Novartis Ag | Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener |
FR2924944A1 (fr) * | 2007-12-18 | 2009-06-19 | Galderma Sa | Composition a base d'une avermectine et du soufre ou d'un derive du soufre, notamment pour le traitement de la rosacee |
BRPI0822980A2 (pt) * | 2008-07-29 | 2015-06-23 | Bomac Research Ltd | Método de fabricação de tabuleta |
WO2011027333A1 (en) * | 2009-09-07 | 2011-03-10 | Douglas Robert Cleverly | Granulated anthelmintic preparations and delivery systems |
CA2814082A1 (en) * | 2010-10-12 | 2012-04-19 | Bayer Intellectual Property Gmbh | Non-starch based soft chewables |
WO2014033230A1 (fr) | 2012-08-31 | 2014-03-06 | Friulchem Spa | Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations |
DK2755498T3 (en) * | 2011-09-15 | 2018-05-22 | Friulchem Spa | COMPOSITION FOR ORAL ADMINISTRATION FOR ANIMALS AND PROCEDURE FOR OBTAINING |
EP2594258B1 (en) * | 2011-11-18 | 2020-03-18 | Veterinärmedizinische Universität Wien | Oral gel comprising praziquantel |
HUE041514T2 (hu) | 2012-02-06 | 2019-05-28 | Merial Inc | Szisztémásan ható hatóanyagokat tartalmazó, parazitaellenes, szájon át adagolt állatgyógyászati készítmények, eljárások és alkalmazásuk |
WO2013150052A1 (en) * | 2012-04-04 | 2013-10-10 | Intervet International B.V. | Soft chewable pharmaceutical products |
KR101348687B1 (ko) * | 2012-05-03 | 2014-01-16 | 남원모 | 사료첨가용 은나노 조성물 |
CA2906295C (en) | 2013-03-15 | 2019-01-22 | Argenta Manufacturing Limited | Chewable formulation |
CN103993061B (zh) * | 2014-05-20 | 2018-03-23 | 海南美合泰生物科技有限公司 | 一种鱼胶原蛋白的生产方法 |
RS62130B1 (sr) | 2015-05-20 | 2021-08-31 | Boehringer Ingelheim Animal Health Usa Inc | Antihelmintička depsipeptidna jedinjenja |
US9808010B2 (en) | 2015-07-06 | 2017-11-07 | Virbac Corporation | Chewable composition |
UY37137A (es) | 2016-02-24 | 2017-09-29 | Merial Inc | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos |
KR102419769B1 (ko) | 2016-08-11 | 2022-07-13 | 아다미스 파마슈티칼스 코포레이션 | 약물 조성물 |
WO2018039508A1 (en) | 2016-08-25 | 2018-03-01 | Merial, Inc. | Method for reducing unwanted effects in parasiticidal treatments |
WO2018093920A1 (en) | 2016-11-16 | 2018-05-24 | Merial, Inc. | Anthelmintic depsipeptide compounds |
CA3046275A1 (en) * | 2016-12-09 | 2018-06-14 | Bayer Animal Health Gmbh | Pharmaceutical preparation and method for its manufacture |
WO2019113493A1 (en) | 2017-12-08 | 2019-06-13 | Adamis Pharmaceuticals Corporation | Drug compositions |
SG11202012922VA (en) | 2018-07-09 | 2021-01-28 | Boehringer Ingelheim Animal Health Usa Inc | Anthelminthic heterocyclic compounds |
EP3883648A1 (en) | 2018-11-20 | 2021-09-29 | Boehringer Ingelheim Animal Health USA Inc. | Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof |
KR20220002890A (ko) | 2019-03-19 | 2022-01-07 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | 구충성 아자-벤조티오펜 및 아자-벤조푸란 화합물 |
TW202122077A (zh) * | 2019-09-06 | 2021-06-16 | 美商拜耳保健責任有限公司 | 適口軟咀嚼物 |
CN113134008B (zh) * | 2020-01-17 | 2022-08-30 | 中国农业大学 | 宠物用伊维菌素吡喹酮咀嚼片及其制备方法 |
KR20230028268A (ko) | 2020-05-29 | 2023-02-28 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | 구충성 헤테로시클릭 화합물 |
EP4208155A1 (en) * | 2020-09-03 | 2023-07-12 | Elanco Tiergesundheit AG | Chewable formulations |
WO2022133420A1 (en) | 2020-12-18 | 2022-06-23 | Boehringer Ingelheim Animal Health USA Inc. | Boron containing pyrazole compounds, compositions comprising them, methods and uses thereof |
WO2023198476A1 (en) | 2022-04-15 | 2023-10-19 | Krka, D.D., Novo Mesto | Soft chewable veterinary dosage form |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3615728A (en) * | 1968-10-11 | 1971-10-26 | Us Agriculture | Method for imparting hickory smoke color and flavor to dried yeast and other food powders |
US3773525A (en) * | 1970-08-31 | 1973-11-20 | A Pittet | Flavoring with bicyclic dehydropiperazines |
ZA741203B (en) * | 1973-03-23 | 1975-01-29 | Smithkline Corp | Veterinary feed compositions for inhibiting rumen microbial deamination |
NZ247278A (en) * | 1991-02-12 | 1995-03-28 | Ancare Distributors | Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier |
US5180720A (en) * | 1991-05-03 | 1993-01-19 | G. D. Searle & Co. | 2- and 3-alkoxy or hydroxy-8-substituted-dibenz[b,f]-[1,4]oxazepine-10(11H)-carboxylic acid, substituted hydrazides and methods for treating pain |
US5380535A (en) * | 1991-05-28 | 1995-01-10 | Geyer; Robert P. | Chewable drug-delivery compositions and methods for preparing the same |
AU653423B2 (en) * | 1991-05-28 | 1994-09-29 | Mcneil-Ppc, Inc. | Chewable drug-delivery composition |
US5477815A (en) * | 1992-08-20 | 1995-12-26 | Booda Products, Inc. | Dog chew toy |
CA2138812A1 (en) * | 1993-12-28 | 1995-06-29 | Akihiko Ishida | Indane derivative and processes for preparing the same |
NZ278126A (en) * | 1994-02-16 | 1996-12-20 | Bettacare Ltd | Infant car seat: tensionable flexible sheet provided to adjust radius of curvature of seat back to suit different sized infants |
US5894029A (en) * | 1994-03-21 | 1999-04-13 | Purebred Pet Products, Inc. | Method of making pet snack food |
SI0760648T1 (en) * | 1994-05-20 | 2002-04-30 | Janssen Pharmaceutica N.V. | Chewable flubendazole tablets for companion animals |
AUPM969994A0 (en) * | 1994-11-28 | 1994-12-22 | Virbac S.A. | Equine anthelmintic formulations |
US5637313A (en) * | 1994-12-16 | 1997-06-10 | Watson Laboratories, Inc. | Chewable dosage forms |
US5962499A (en) * | 1995-03-20 | 1999-10-05 | Merck & Co., Inc. | Nodulisporic acid derivatives |
US6221894B1 (en) * | 1995-03-20 | 2001-04-24 | Merck & Co., Inc. | Nodulisporic acid derivatives |
US5747058A (en) * | 1995-06-07 | 1998-05-05 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
CA2178686A1 (en) * | 1995-06-13 | 1996-12-14 | Leslie G. Humber | Oral formulations of s(+)-etodolac |
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5958888A (en) * | 1996-07-02 | 1999-09-28 | Merial, Inc. | Water miscible macrolide solutions |
US5827565A (en) * | 1996-10-25 | 1998-10-27 | T.F.H. Publications, Inc. | Process for making an edible dog chew |
US6110521A (en) * | 1996-10-25 | 2000-08-29 | T.F.H. Publications, Inc. | Wheat and casein dog chew with modifiable texture |
US6200616B1 (en) * | 1996-10-25 | 2001-03-13 | Tfh Publications, Inc. | Animal chew |
US6126978A (en) * | 1996-10-25 | 2000-10-03 | T.F.H. Publications, Inc. | Edible dog chew |
US6093427A (en) * | 1997-09-03 | 2000-07-25 | T.F.H.Publications, Inc. | Vegetable-based dog chew |
US6086940A (en) * | 1996-10-25 | 2000-07-11 | T.F.H. Publications, Inc. | High starch content dog chew |
US5904937A (en) * | 1997-10-03 | 1999-05-18 | Fmc Corporation | Taste masked pharmaceutical compositions |
US6239112B1 (en) * | 1998-07-09 | 2001-05-29 | Merial, Inc. | Water miscible macrolide solutions |
US6093441A (en) * | 1998-07-15 | 2000-07-25 | Tfh Publications, Inc. | Heat modifiable peanut dog chew |
US6174540B1 (en) * | 1998-09-14 | 2001-01-16 | Merck & Co., Inc. | Long acting injectable formulations containing hydrogenated caster oil |
GB9825402D0 (en) * | 1998-11-19 | 1999-01-13 | Pfizer Ltd | Antiparasitic formulations |
US6159516A (en) * | 1999-01-08 | 2000-12-12 | Tfh Publication, Inc. | Method of molding edible starch |
US6274182B1 (en) * | 1999-11-19 | 2001-08-14 | Tfh Publications, Inc. | Animal chew |
US6787342B2 (en) * | 2000-02-16 | 2004-09-07 | Merial Limited | Paste formulations |
US6340672B1 (en) * | 2000-02-16 | 2002-01-22 | Phoenix Scientific, Inc. | Parasiticidal formulation and a method of making this formulation |
US6207179B1 (en) * | 2000-05-18 | 2001-03-27 | Phoenix Scientific, Inc. | Parasiticidal formulation for animals and a method of making this formulation |
US6399786B1 (en) * | 2000-07-14 | 2002-06-04 | Merck & Co., Inc. | Nonacyclic nodulisporic acid derivatives |
DK1197215T3 (da) * | 2000-10-10 | 2006-07-10 | Wyeth Corp | Anthelmintiske sammensætninger |
EP1247456A3 (en) * | 2001-02-28 | 2003-12-10 | Pfizer Products Inc. | Palatable pharmaceutical compositions for companion animals |
US6787642B2 (en) * | 2001-03-23 | 2004-09-07 | The Regents Of The University Of California | Use of insect cell membrane transporters as novel target sites for inspection |
US20030064941A1 (en) * | 2001-05-21 | 2003-04-03 | Pfizer Inc. | Avermectin and praziquantel combination therapy |
US20030190343A1 (en) * | 2002-03-05 | 2003-10-09 | Pfizer Inc. | Palatable pharmaceutical compositions for companion animals |
-
2003
- 2003-12-23 US US10/745,784 patent/US20040151759A1/en not_active Abandoned
-
2004
- 2004-12-17 WO PCT/US2004/042380 patent/WO2005062782A2/en active Application Filing
- 2004-12-17 JP JP2006547151A patent/JP2007516285A/ja active Pending
- 2004-12-17 EP EP04814549A patent/EP1702056A4/en not_active Withdrawn
- 2004-12-17 AU AU2004308284A patent/AU2004308284A1/en not_active Abandoned
- 2004-12-17 CN CNA2004800411573A patent/CN1972672A/zh active Pending
- 2004-12-17 BR BRPI0418098-4A patent/BRPI0418098A/pt not_active Application Discontinuation
- 2004-12-17 KR KR1020067014626A patent/KR20060126728A/ko not_active Application Discontinuation
-
2006
- 2006-06-22 CR CR8480A patent/CR8480A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2007516285A (ja) | 2007-06-21 |
WO2005062782A3 (en) | 2006-08-10 |
EP1702056A4 (en) | 2012-05-02 |
EP1702056A2 (en) | 2006-09-20 |
US20040151759A1 (en) | 2004-08-05 |
CR8480A (es) | 2007-04-24 |
CN1972672A (zh) | 2007-05-30 |
KR20060126728A (ko) | 2006-12-08 |
WO2005062782A2 (en) | 2005-07-14 |
AU2004308284A1 (en) | 2005-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0418098A (pt) | formulações veterinárias não contendo produtos animais | |
BR0313528A (pt) | Formulações veterinárias contendo produto não-animal | |
BR9808581A (pt) | Estabilização de benzimidazóis sensìveis a ácido com combinações de aminoácido/ciclodextrina | |
DK1299108T3 (da) | Parasiticidt præparat samt fremgangsmåde til fremstilling af dette præparat | |
DE69926386D1 (de) | Propofol-formulierung | |
BRPI0409185A (pt) | formulações veterinárias anti-helmìnticas tópicas | |
PT1207756E (pt) | Utilizacao de espinosade ou de uma formulacao que compreende espinosade | |
EA200100458A1 (ru) | Антипаразитарные препараты | |
DE60034778D1 (de) | Stoppen, schützen und konservieren von organen | |
PT1073467E (pt) | Formulacoes de co-solvente que compreendem um composo de vitamina d. | |
CY1107789T1 (el) | Ανθελμινθικαι συνθεσεις περιεχουσαι συνδυασμους αβερμεκτινων ή μιλβεμυκινων μετα δις-αρυλο ενωσεων | |
KR20100038118A (ko) | 체내구충 국소 조성물 | |
CA2364742A1 (en) | Anthelmintic composition | |
ATE286736T1 (de) | Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin | |
TNSN07285A1 (en) | Anthelmintic composition | |
DK0930077T3 (da) | Cyclodextrinpræparater indeholdende et avermectin- eller milbemycinderivat | |
BR0013283A (pt) | Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo | |
ATE207492T1 (de) | Difluoroavermectin-derivate | |
WO2005023175A3 (en) | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound | |
WO2008077130A3 (en) | Homogeneous paste and gel formulations | |
JO2129B1 (en) | A non-aqueous compound that repels intestinal worms | |
BRPI0309768B8 (pt) | composição lubrificante substancialmente anidra | |
CA2622713A1 (en) | Anthelmintic formulations | |
KR20200050565A (ko) | 셀라멕틴을 포함하는 구충제 조성물 | |
ES2187446T3 (es) | Composicion para el tratamiento de la psoriasis. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: MERIAL, INC. (US) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |